BCL2 and ovarian cancer: MIR4435-2HG knockdown increases the apoptosis rate, downregulates BCL-2 expression of ovarian cancer cells, and decreases tumor size in animal models via the MIR4435-2HG/miR-128-3p axis (Zhu et al., 2020[160]).